Trial Profile
The role of apixaban, aspirin and enoxaparin as Thromboprophylaxis in patients newly diagnosed with Multiple Myeloma - an open label randomised control clinical trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Aspirin; Enoxaparin sodium
- Indications Venous thromboembolism
- Focus Adverse reactions
- Acronyms TiMM
- 01 Jul 2019 This trial has been Discontinued in UK - MHRA, according to European Clinical Trials Database.
- 28 Apr 2016 New trial record